Cancer-cell-derived EVs can also carry PD-L1 to other cancer cells that are PD-L1-deficient, thus inhibiting cancer immunity mediated by T cells and promoting immune invasion by the tumor cells [42]. Here, CD274 is linked to neoplasm.